MitoCell(Taiwan Mitochondrion Applied Technology)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMitoCell(Taiwan Mitochondrion Applied Technology)
Drug Alias Nameautologous TM01-treated adipose-derived mesenchymal stem cellsAadipose-Derived Mesenchymal Stem Cells
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTaiwan Mitochondrion Applied Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaiwan Mitochondrion Applied Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A